Standard

Towards modeling anhedonia and its treatment in zebrafish. / de Abreu, M.S.; Costa, Fabiano V.; Giacomini, Ana C.V.V.; Demin, Konstantin A. ; Zabegalov, Konstantin N. ; Maslov, Gleb O. ; Kositsyn, Yuriy M. ; Petersen, Elena V.; Strekalova, Tatyana; Rosemberg, Denis B.; Kalueff, Allan V. .

In: International Journal of Neuropsychopharmacology, 12.2021.

Research output: Contribution to journal › Article › peer-review

Harvard

de Abreu, MS, Costa, FV, Giacomini, ACVV, Demin, KA, Zabegalov, KN, Maslov, GO, Kositsyn, YM, Petersen, EV, Strekalova, T, Rosemberg, DB & Kalueff, AV 2021, 'Towards modeling anhedonia and its treatment in zebrafish', International Journal of Neuropsychopharmacology.

APA

de Abreu, M. S., Costa, F. V., Giacomini, A. C. V. V., Demin, K. A., Zabegalov, K. N., Maslov, G. O., Kositsyn, Y. M., Petersen, E. V., Strekalova, T., Rosemberg, D. B., & Kalueff, A. V. (2021). Towards modeling anhedonia and its treatment in zebrafish. International Journal of Neuropsychopharmacology, [34918075].

Vancouver

de Abreu MS, Costa FV, Giacomini ACVV, Demin KA, Zabegalov KN, Maslov GO et al. Towards modeling anhedonia and its treatment in zebrafish. International Journal of Neuropsychopharmacology. 2021 Dec. 34918075.

Author

de Abreu, M.S. ; Costa, Fabiano V. ; Giacomini, Ana C.V.V. ; Demin, Konstantin A. ; Zabegalov, Konstantin N. ; Maslov, Gleb O. ; Kositsyn, Yuriy M. ; Petersen, Elena V. ; Strekalova, Tatyana ; Rosemberg, Denis B. ; Kalueff, Allan V. . / Towards modeling anhedonia and its treatment in zebrafish. In: International Journal of Neuropsychopharmacology. 2021.

BibTeX

@article{e5cf21676cd84a5aaebb16d9866186c7,
title = "Towards modeling anhedonia and its treatment in zebrafish",
abstract = "Mood disorders, especially depression, are a major cause of human disability. The loss of pleasure (anhedonia) is a common, severely debilitating symptom of clinical depression. Experimental animal models are widely used to better understand depression pathogenesis, and to develop novel antidepressant therapies. In rodents, various experimental models of anhedonia have already been developed and validated. Complementing rodent studies, the zebrafish (Danio rerio) is emerging as a powerful model organism to assess pathobiological mechanisms of affective disorders. Here, we critically discuss the potential of zebrafish for modeling anhedonia and studying its molecular mechanisms and translational implications.",
keywords = "anhedonia, animal models, antidepressant, behavior, zebrafish",
author = "{de Abreu}, M.S. and Costa, {Fabiano V.} and Giacomini, {Ana C.V.V.} and Demin, {Konstantin A.} and Zabegalov, {Konstantin N.} and Maslov, {Gleb O.} and Kositsyn, {Yuriy M.} and Petersen, {Elena V.} and Tatyana Strekalova and Rosemberg, {Denis B.} and Kalueff, {Allan V.}",
note = "S de Abreu M, Costa F, Giacomini ACVV, Demin KA, Zabegalov KN, Maslov GO, Kositsyn YM, Petersen EV, Strekalova T, Rosemberg DB, Kalueff AV. Towards modeling anhedonia and its treatment in zebrafish. Int J Neuropsychopharmacol. 2021 Dec 16:pyab092. doi: 10.1093/ijnp/pyab092. Epub ahead of print. PMID: 34918075.",
year = "2021",
month = dec,
language = "English",
journal = "International Journal of Neuropsychopharmacology",
issn = "1461-1457",
publisher = "Oxford University Press",

}

RIS

TY - JOUR

T1 - Towards modeling anhedonia and its treatment in zebrafish

AU - de Abreu, M.S.

AU - Costa, Fabiano V.

AU - Giacomini, Ana C.V.V.

AU - Demin, Konstantin A.

AU - Zabegalov, Konstantin N.

AU - Maslov, Gleb O.

AU - Kositsyn, Yuriy M.

AU - Petersen, Elena V.

AU - Strekalova, Tatyana

AU - Rosemberg, Denis B.

AU - Kalueff, Allan V.

N1 - S de Abreu M, Costa F, Giacomini ACVV, Demin KA, Zabegalov KN, Maslov GO, Kositsyn YM, Petersen EV, Strekalova T, Rosemberg DB, Kalueff AV. Towards modeling anhedonia and its treatment in zebrafish. Int J Neuropsychopharmacol. 2021 Dec 16:pyab092. doi: 10.1093/ijnp/pyab092. Epub ahead of print. PMID: 34918075.

PY - 2021/12

Y1 - 2021/12

N2 - Mood disorders, especially depression, are a major cause of human disability. The loss of pleasure (anhedonia) is a common, severely debilitating symptom of clinical depression. Experimental animal models are widely used to better understand depression pathogenesis, and to develop novel antidepressant therapies. In rodents, various experimental models of anhedonia have already been developed and validated. Complementing rodent studies, the zebrafish (Danio rerio) is emerging as a powerful model organism to assess pathobiological mechanisms of affective disorders. Here, we critically discuss the potential of zebrafish for modeling anhedonia and studying its molecular mechanisms and translational implications.

AB - Mood disorders, especially depression, are a major cause of human disability. The loss of pleasure (anhedonia) is a common, severely debilitating symptom of clinical depression. Experimental animal models are widely used to better understand depression pathogenesis, and to develop novel antidepressant therapies. In rodents, various experimental models of anhedonia have already been developed and validated. Complementing rodent studies, the zebrafish (Danio rerio) is emerging as a powerful model organism to assess pathobiological mechanisms of affective disorders. Here, we critically discuss the potential of zebrafish for modeling anhedonia and studying its molecular mechanisms and translational implications.

KW - anhedonia

KW - animal models

KW - antidepressant

KW - behavior

KW - zebrafish

UR - https://pubmed.ncbi.nlm.nih.gov/34918075/

M3 - Article

JO - International Journal of Neuropsychopharmacology

JF - International Journal of Neuropsychopharmacology

SN - 1461-1457

M1 - 34918075

ER -

ID: 89531578